2-[4-(2-Pyrimidyl)-1-piperazinyl]acetohydrazide


Chemical Name: 2-[4-(2-Pyrimidyl)-1-piperazinyl]acetohydrazide
CAS Number: 1495336-65-6
Product Number: AG00HXQ0(AGN-PC-0WAM5F)
Synonyms:
MDL No: MFCD19386499
Molecular Formula: C10H16N6O
Molecular Weight: 236.2736

Identification/Properties


Safety Information


GHS Pictogram:
Signal Word:
Warning
UN#:
N/A
Hazard Statements:
H302-H315-H319-H335
Precautionary Statements:
P261-P280-P301+P312-P302+P352-P305+P351+P338
Class:
N/A
Packing Group:
N/A

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



2-[4-(2-Pyrimidyl)-1-piperazinyl]acetohydrazide is a versatile chemical compound that plays a crucial role in chemical synthesis processes. One of its key applications lies in its use as a building block in the creation of novel pharmaceutical compounds. By utilizing its unique structural properties, this compound serves as a valuable intermediate in the synthesis of various drug candidates with potential therapeutic benefits.This compound's hydrazide functional group is particularly significant in organic synthesis, as it can undergo a wide range of chemical reactions to introduce diverse functionalities into the molecule. In pharmaceutical research and development, the introduction of specific functional groups at strategic positions within a molecule is crucial for enhancing biological activity, improving pharmacokinetic properties, and minimizing potential toxicity.Additionally, the presence of the piperazine and pyrimidine moieties in 2-[4-(2-Pyrimidyl)-1-piperazinyl]acetohydrazide further expands its reactivity and opens up possibilities for structural modifications. These structural features enable chemists to tailor the compound's properties to meet the specific requirements of target molecules, thus facilitating the synthesis of new and potent pharmaceutical agents.Overall, the application of 2-[4-(2-Pyrimidyl)-1-piperazinyl]acetohydrazide in chemical synthesis offers a promising avenue for the development of innovative drug candidates with enhanced efficacy and improved therapeutic profiles.